PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CME vs. PSEC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CME and PSEC is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

CME vs. PSEC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CME Group Inc. (CME) and Prospect Capital Corporation (PSEC). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
24.43%
-6.76%
CME
PSEC

Key characteristics

Sharpe Ratio

CME:

1.44

PSEC:

-0.42

Sortino Ratio

CME:

2.01

PSEC:

-0.39

Omega Ratio

CME:

1.25

PSEC:

0.94

Calmar Ratio

CME:

1.59

PSEC:

-0.30

Martin Ratio

CME:

4.69

PSEC:

-1.04

Ulcer Index

CME:

5.00%

PSEC:

10.32%

Daily Std Dev

CME:

16.24%

PSEC:

25.16%

Max Drawdown

CME:

-77.50%

PSEC:

-61.51%

Current Drawdown

CME:

-0.75%

PSEC:

-29.40%

Fundamentals

Market Cap

CME:

$89.68B

PSEC:

$1.97B

EPS

CME:

$9.66

PSEC:

-$0.21

PEG Ratio

CME:

7.86

PSEC:

1.59

Total Revenue (TTM)

CME:

$6.13B

PSEC:

$504.47M

Gross Profit (TTM)

CME:

$5.28B

PSEC:

$389.24M

EBITDA (TTM)

CME:

$4.54B

PSEC:

$298.67M

Returns By Period

In the year-to-date period, CME achieves a 7.17% return, which is significantly higher than PSEC's 4.09% return. Over the past 10 years, CME has outperformed PSEC with an annualized return of 14.53%, while PSEC has yielded a comparatively lower 4.88% annualized return.


CME

YTD

7.17%

1M

7.03%

6M

24.43%

1Y

19.48%

5Y*

7.88%

10Y*

14.53%

PSEC

YTD

4.09%

1M

2.42%

6M

-6.76%

1Y

-11.50%

5Y*

3.82%

10Y*

4.88%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CME vs. PSEC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CME
The Risk-Adjusted Performance Rank of CME is 8282
Overall Rank
The Sharpe Ratio Rank of CME is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of CME is 8080
Sortino Ratio Rank
The Omega Ratio Rank of CME is 7777
Omega Ratio Rank
The Calmar Ratio Rank of CME is 8787
Calmar Ratio Rank
The Martin Ratio Rank of CME is 8080
Martin Ratio Rank

PSEC
The Risk-Adjusted Performance Rank of PSEC is 2424
Overall Rank
The Sharpe Ratio Rank of PSEC is 2424
Sharpe Ratio Rank
The Sortino Ratio Rank of PSEC is 2323
Sortino Ratio Rank
The Omega Ratio Rank of PSEC is 2121
Omega Ratio Rank
The Calmar Ratio Rank of PSEC is 2929
Calmar Ratio Rank
The Martin Ratio Rank of PSEC is 2222
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CME vs. PSEC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Prospect Capital Corporation (PSEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CME, currently valued at 1.44, compared to the broader market-2.000.002.001.44-0.42
The chart of Sortino ratio for CME, currently valued at 2.01, compared to the broader market-4.00-2.000.002.004.006.002.01-0.39
The chart of Omega ratio for CME, currently valued at 1.25, compared to the broader market0.501.001.502.001.250.94
The chart of Calmar ratio for CME, currently valued at 1.59, compared to the broader market0.002.004.006.001.59-0.30
The chart of Martin ratio for CME, currently valued at 4.69, compared to the broader market-10.000.0010.0020.0030.004.69-1.04
CME
PSEC

The current CME Sharpe Ratio is 1.44, which is higher than the PSEC Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of CME and PSEC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50SeptemberOctoberNovemberDecember2025February
1.44
-0.42
CME
PSEC

Dividends

CME vs. PSEC - Dividend Comparison

CME's dividend yield for the trailing twelve months is around 4.18%, less than PSEC's 15.20% yield.


TTM20242023202220212020201920182017201620152014
CME
CME Group Inc.
4.18%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%4.38%
PSEC
Prospect Capital Corporation
15.20%16.01%12.02%10.30%9.27%13.31%11.18%11.41%13.41%11.93%14.67%16.04%

Drawdowns

CME vs. PSEC - Drawdown Comparison

The maximum CME drawdown since its inception was -77.50%, which is greater than PSEC's maximum drawdown of -61.51%. Use the drawdown chart below to compare losses from any high point for CME and PSEC. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-0.75%
-29.40%
CME
PSEC

Volatility

CME vs. PSEC - Volatility Comparison

CME Group Inc. (CME) has a higher volatility of 5.17% compared to Prospect Capital Corporation (PSEC) at 4.82%. This indicates that CME's price experiences larger fluctuations and is considered to be riskier than PSEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
5.17%
4.82%
CME
PSEC

Financials

CME vs. PSEC - Financials Comparison

This section allows you to compare key financial metrics between CME Group Inc. and Prospect Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab